Contemporary management of sinonasal cancer

Head and Neck

Volumn 33, Issue 9, 2011, Pages 1352-1365

  Robbins, K Thomas ^a   Ferlito, Alfio ^b   Silver, Carl E ^c   Takes, Robert P ^d   Strojan, Primoa ^e   Snyderman, Carl H ^f   De Bree, Remco ^g   Haigentz Jr , Missak ^c   Langendijk, Johannes A ^h   Rinaldo, Alessandra ^b   Shaha, Ashok R ⁱ   Hanna, Ehab Y ^j   Werner, Jochen A ^k   Suárez, Carlos ^l  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UDINE   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e INSTITUTE OF ONCOLOGY   (Slovenia)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j UNIVERSITY OF TEXAS   (United States)

^k PHILIPPS UNIVERSITY MARBURG   (Germany)

^l HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

more..

Author keywords

chemotherapy; endoscopic surgical resection; quality of life; radiation therapy; sinonasal cancer; treatment

Indexed keywords

CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; HYDROXYUREA; IMATINIB; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADVANCED CANCER; BILATERAL BLINDNESS; BLINDNESS; BONE NECROSIS; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CEREBROSPINAL FLUID OTORRHEA; CHEMORADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CRANIOFACIAL SURGERY; DISEASE CONTROL; DISEASE FREE SURVIVAL; ENDOSCOPIC SINUS SURGERY; ESTHESIONEUROBLASTOMA; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; HUMAN; HYPOPITUITARISM; INTENSITY MODULATED RADIATION THERAPY; IPSILATERAL BLINDNESS; JAW OSTEONECROSIS; MENINGITIS; MULTIMODALITY CANCER THERAPY; NEOVASCULAR GLAUCOMA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARANASAL SINUS CANCER; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INDUCED RETINOPATHY; RADIATION NECROSIS; RADICAL RESECTION; RETINOPATHY; REVIEW; SINONASAL CANCER; SURGICAL MORTALITY; SYSTEMATIC REVIEW; THERAPY EFFECT; TOPICAL CHEMOTHERAPY; TOPICAL TREATMENT; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; ENDOSCOPY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NASAL CAVITY; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PROTEIN KINASE INHIBITORS; QUALITY OF LIFE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 80051766498     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21515     Document Type: Review

References (75)

1. Suárez C, Ferlito A, Lund VJ, et al. Management of the orbit in malignant sinonasal tumors. Head Neck 2008; 30: 242-250. (Pubitemid 351251709)
2. Guntinas-Lichius O, Kreppel MP, Stuetzer H, Semrau R, Eckel HE, Mueller RP,. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol 2007; 33: 222-228. (Pubitemid 46349947)
3. Dulguerov P, Jacobsen MS, Allal AA, Lehmann W, Calcaterra T,. Nasal and paranasal sinus carcinoma: are we making progress? Cancer 2001; 92: 3012-3029.
4. Jansen EPM, Keus RB, Hilgers FJ, Haas RL, Tan IB, Bartelink H,. Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? Int J Radiat Oncol Biol Phys 2000; 48: 27-35. (Pubitemid 30488209)
5. Mendenhall WM, Amdur RJ, Morris CG, et al. Carcinoma of the nasal cavity and paranasal sinuses. Laryngoscope 2009; 119: 899-906.
6. Snyers A, Janssens GO, Twickler MB, et al. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Int J Radiat Oncol Biol Phys 2009; 73: 1343-1351.
7. Ganly I, Patel SG, Singh B, et al. Craniofacial resection for malignant paranasal sinus tumors: report of an International Collaborative Study. Head Neck 2005; 27: 575-584. (Pubitemid 40961065)
8. Suárez C, Llorente JL, Fernández de Leõn R, Maseda E,. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004; 26: 136-144. (Pubitemid 38160447)
9. Suárez C, Llorente JL, Fernández de Leõn R, Cabanillas R, Suárez V, Lõpez A,. Anterior craniofacial resection: oncologic outcome and complications in a series of 111 cases. [Article in Spanish] Acta Otorrinolaringol Esp 2004; 55: 27-33. (Pubitemid 47251310)
10. Carrau RL, Segas J, Nuss DW, et al. Squamous cell carcinoma of the sinonasal tract invading the orbit. Laryngoscope 1999; 109: 230-235. (Pubitemid 29075565)
11. Nazar G, Rodrigo JP, Llorente JL, Baragaño L, Suárez C,. Prognostic factors of maxillary sinus malignancies. Am J Rhinol 2004; 18: 233-238. (Pubitemid 39302826)
12. Imola MJ, Schramm VL Jr,. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope 2002; 112: 1357-1365. (Pubitemid 34875417)
13. Stammberger H, Anderhuber W, Walch C, Papaefthymiou G,. Possibilities and limitations of endoscopic management of nasal and paranasal sinus malignancies. Acta Otorhinolaryngol Belg 1999; 53: 199-205.
14. Carrau RL, Kassam AB, Snyderman CH, Duvvuri U, Mintz A, Gardner P,. Endoscopic transnasal anterior skull base resection for the treatment of sinonasal malignancies. Oper Tech Otolaryngol Head Neck Surg 2006; 17: 102-110. (Pubitemid 43827579)
15. Lund V, Howard DJ, Wei WI,. Endoscopic resection of malignant tumors of the nose and sinuses. Am J Rhinol 2007; 21: 89-94. (Pubitemid 46231497)
16. Podboj J, Šmid L,. Endoscopic surgery with curative intent for malignant tumors of the nose and paranasal sinuses. Eur J Surg Oncol 2007; 33: 1081-1086. (Pubitemid 350002344)
17. Nicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience. Am J Rhinol 2008; 22: 308-316. (Pubitemid 351846814)
18. Hanna E, DeMonte F, Ibrahim S, Roberts D, Levine N, Kupferman M,. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg 2009; 135: 1219-1224.
19. Batra PS, Luong A, Kanowitz SJ, et al. Outcomes of minimally invasive endoscopic resection of anterior skull base neoplasms. Laryngoscope 2010; 120: 9-16.
20. Homma A, Saheki M, Suzuki F, Fukuda S,. Computer image-guided surgery for total maxillectomy. Eur Arch Otorhinolaryngol 2008; 265: 1521-1526.
21. Devaiah AK, Andreoli MT,. Treatment of esthesioneuroblastoma: a 16 year meta-analysis of 361 patients. Laryngoscope 2009; 119: 1412-1416.
22. Snyderman CH, Carrau RL, Kassam AB, et al. Endoscopic skull base surgery: principles of endonasal oncological surgery. J Surg Oncol 2008; 97: 658-664. (Pubitemid 351812966)
23. Pant H, Bhatki AM, Snyderman CH, et al. Quality of life following endonasal skull base surgery. Skull Base 2010; 20: 35-40.
24. Samant S, Robbins KT, Vang M, Wan J, Robertson J,. Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 948-955. (Pubitemid 39045602)
25. Samant S, Robbins KT, Kumar P, Ma JZ, Vieira F, Hanchett C,. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolaryngol Head Neck Surg 2001; 127: 1451-1456. (Pubitemid 33150610)
26. Hoppe BS, Nelson CJ, Gomez DR, et al. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008; 72: 763-769.
27. Gabriele AM, Airoldi M, Garzaro M, et al. Stage III-IV sinonasal and nasal cavity carcinoma treated with three-dimensional conformal radiotherapy. Tumori 2008; 94: 320-326.
28. Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-the MSKCC experience. Int J Radiat Oncol Biol Phys 2007; 67: 691-702. (Pubitemid 46215869)
29. Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W,. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009; 73: 424-432.
30. Daly ME, Chen AM, Bucci MK, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2007; 67: 151-157. (Pubitemid 44959503)
31. Chen AM, Daly ME, Bucci MK, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007; 69: 141-147. (Pubitemid 47247504)
32. Monroe AT, Bhandare N, Morris CG, Mendenhall WM,. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005; 61: 856-864. (Pubitemid 40247982)
33. Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM,. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 2005; 62: 1070-1077. (Pubitemid 40884419)
34. Miralbell R, Crowell C, Suit HD,. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 1992; 22: 305-310.
35. Lomax AJ, Goitein M, Adams J,. Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 2003; 66: 11-18. (Pubitemid 36135999)
36. Mock U, Georg D, Bogner J, Auberger T, Pötter R,. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 2004; 58: 147-154. (Pubitemid 38010348)
37. Chera BS, Malyapa R, Louis D, et al. Proton therapy for maxillary sinus carcinoma. Am J Clin Oncol 2009; 32: 296-303.
38. Resto VA, Chan AW, Deschler DG, Lin DT,. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008; 30: 222-229. (Pubitemid 351251706)
39. Rosen A, Vokes EE, Scher N, Haraf D, Weichselbaum RR, Panje WR,. Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg 1993; 119: 743-746. (Pubitemid 23198692)
40. Lee MM, Vokes EE, Rosen A, Witt ME, Weichselbaum RR, Haraf DJ,. Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am 1999; 5: 219-223. (Pubitemid 29528749)
41. Choi KN, Rotman M, Aziz H, et al. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors. Int J Radiat Oncol Biol Phys 1997; 39: 823-829. (Pubitemid 27486069)
42. Sato Y, Morita M, Takahashi HO, Watanabe N, Kirikae I,. Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer 1970; 25: 571-579.
43. Tsujii H, Kamada T, Arimoto T, et al. The role of radiotherapy in the management of maxillary sinus carcinoma. Cancer 1986; 57: 2261-2266. (Pubitemid 16118960)
44. Konno A, Ishikawa K, Terada N, Numata T, Nagata H, Okamoto Y,. Analysis of long-term results of our combination therapy for squamous cell cancer of the maxillary sinus. Acta Otolaryngol Suppl 1998; 537: 57-66. (Pubitemid 28545378)
45. Nishino H, Miyata M, Morita M, Ishikawa K, Kanazawa T, Ichimura K,. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer 2000; 89: 1925-1932.
46. Robbins KT, Kumar P, Wong FSH, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000; 22: 687-693.
47. Homma A, Oridate N, Suzuki F, et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009; 115: 4705-4714.
48. Knegt PP, Ah-See KW, vd Velden LA, Kerrebijn J,. Adenocarcinoma of the ethmoidal sinus complex: surgical debulking and topical fluorouracil may be the optimal treatment. Arch Otolaryngol Head Neck Surg 2001; 127: 141-146. (Pubitemid 32163639)
49. Almeyda R, Capper J,. Is surgical debridement and topical 5 fluorouracil the optimum treatment for woodworkers' adenocarcinoma of the ethmoid sinuses? A case-controlled study of a 20-year experience. Clin Otolaryngol 2008; 33: 435-441.
50. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11: 21-28.
51. Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol 2010; 28: 8-14.
52. Vila L, Liu H, Al-Quran SZ, Coco DP, Dong HJ, Liu C,. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol 2009; 22: 1296-1302.
53. Alcedo JC, Fábrega JM, Arosemena JR, Urrutia A,. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck 2004; 26: 829-831. (Pubitemid 39159307)
54. Faivre S, Raymond E, Casiraghi O, Temam S, Berthaud P,. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol 2005; 23: 6271-6273.
55. Pfeffer MR, Talmi Y, Catane R, Symon Z, Yosepovitch A, Levitt M,. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 2007; 43: 33-36. (Pubitemid 46162246)
56. Hotte SJ, Winquist EW, Lamont E, et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 2005; 23: 585-590. (Pubitemid 46224236)
57. Dirix P, Nuyts S, Geussens Y, et al. Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 1042-1050. (Pubitemid 47625837)
58. Waldron JN, O'Sullivan B, Gullane P, et al. Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol 2000; 57: 167-173.
59. Jeremic B, Nguyen-Tan PF, Bamberg M,. Elective neck irradiation in locally advanced squamous cell carcinoma of the maxillary sinus: a review. J Cancer Res Clin Oncol 2002; 128: 235-238. (Pubitemid 34591580)
60. Bristol IJ, Ahamad A, Garden AS, et al. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 2007; 68: 719-730. (Pubitemid 46818748)
61. Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA,. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 1986; 10: 771-779. (Pubitemid 17176939)
62. Rischin D, Porceddu S, Peters L, Martin J, Corry J, Weih L,. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck 2004; 26: 435-441. (Pubitemid 38569202)
63. Chen AM, Daly ME, El-Sayed I, et al. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2008; 70: 338-343.
64. Zhen W, Hoffman HT, Mayr NA, et al. Primary neuroendocrine carcinoma of the head and neck: the University of Iowa experience. Abstract and Proceedings of American Society of Clinical Oncology 1999; 18: 410A.
65. Diaz EM Jr, Kies MS,. Chemotherapy for skull base cancers. Otolaryngol Clin North Am 2001; 34: 1079-1085. (Pubitemid 33095898)
66. Rhee CS, Won TB, Lee CH, et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope 2006; 116: 982-986. (Pubitemid 44318002)
67. Lupinetti AD, Roberts DB, Williams MD, et al. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer 2007; 110: 2726-2731. (Pubitemid 350250342)
68. Samant S, van den Brekel MW, Kies M, et al. Upfront concurrent chemoradiation for advanced unresectable adenoid cystic carcinoma of the head and neck: a 3-institution experience. Abstract presented at the 7th International Conference on Head and Neck Cancer, July 19-23, 2008, San Francisco, CA.
69. Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ,. Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol 2002; 122: 215-221. (Pubitemid 34270831)
70. Ferlito A, Rinaldo A, Rhys-Evans PH,. Esthesioneuroblastoma: an update on management of the neck. Laryngoscope 2003; 113: 1935-1938. Erratum in: Laryngoscope 2003;113:2227.
71. Gore MR, Zanation AM,. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol Head Neck Surg 2009; 135: 1030-1034.
72. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH,. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000; 22: 550-558. (Pubitemid 30663069)
73. Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998; 42: 1029-1037. (Pubitemid 28196514)
74. Jones E, Lund VJ, Howard DJ, Greenberg MP, McCarthy M,. Quality of life of patients treated surgically for head and neck cancer. J Laryngol Otol 1992; 106: 238-242.
75. Ferlito A, Takes RP, Rinaldo A, Devaney KO,. Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer? Eur Arch Otorhinolaryngol 2010; 267: 325-326.